Sei Investments Co. Lowers Position in Danaher Corporation $DHR

Sei Investments Co. decreased its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 32.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 703,077 shares of the conglomerate’s stock after selling 342,434 shares during the period. Sei Investments Co.’s holdings in Danaher were worth $133,310,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth about $25,000. Main Street Group LTD purchased a new stake in shares of Danaher during the 1st quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth approximately $26,000. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher in the fourth quarter valued at approximately $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

  • Positive Sentiment: Several commentary pieces say the post-earnings drop may have created a buying opportunity, with Barron’s arguing investors should not abandon Danaher (DHR) after the sharp reaction and suggesting the stock could rebound. Article: Don’t Quit on Danaher Stock After Horrific Earnings Reaction
  • Positive Sentiment: One technical-market update said the selloff may be showing signs of capitulation, and noted some bullish trading activity in the shares, which could indicate downside pressure is easing. Article: Stock Of The Day: Is The Danaher Selloff Over?
  • Positive Sentiment: Wall Street analysts still see meaningful upside from current levels, with one note highlighting a consensus price target implying about 32% potential gain and improving earnings estimate revisions. Article: Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?
  • Neutral Sentiment: Danaher’s Q2 2026 earnings call transcript was published, giving investors a fresh look at management’s commentary and the company’s outlook, but the transcript itself does not change fundamentals. Article: Danaher (DHR) Q2 2026 Earnings Call Transcript
  • Neutral Sentiment: Unusual options activity showed elevated put buying in Danaher (DHR), suggesting some traders are hedging for further downside or volatility after the earnings-driven move.
  • Negative Sentiment: Recent coverage says the stock’s sharp decline was driven by Q2 results where a beat on earnings was overshadowed by bioprocessing weakness and analyst price-target cuts, which remain the main bearish overhang on the shares. Article: Stock Of The Day: Is The Danaher Selloff Over?

Danaher Stock Up 7.5%

Shares of NYSE:DHR opened at $192.52 on Friday. The company has a market capitalization of $135.34 billion, a price-to-earnings ratio of 34.20, a price-to-earnings-growth ratio of 2.19 and a beta of 0.79. The company has a 50 day moving average of $185.05 and a two-hundred day moving average of $197.07. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.77 earnings per share. As a group, analysts forecast that Danaher Corporation will post 8.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. UBS Group decreased their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. HSBC cut their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Evercore reaffirmed an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Finally, Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Read Our Latest Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.